U.S. Stem Cell, Inc. Stock Predictions

OTC Markets Group > Healthcare > Biotechnology

Open Broker Account

$0.000001

+0 (+0%)

At Close: Apr 08, 2024

Currently predicting for Mon, 6 May 2024

USRM Predictions History

4 years ago
NameNotImportant predicted that USRM for 2019-05-06 is going $0.0210 (-4.11%)

6 years ago
Mi.Zhang.19740 predicted that USRM for 2018-03-23 is going $0.0210 (-70.38%)

Rank:

About U.S. Stem Cell, Inc.

U.S. Stem Cell, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of autologous cellular therapies for the treatment of chronic and acute heart damage, and vascular and autoimmune diseases in the United States. The company's lead product candidates include MyoCell, a clinical therapy designed to populate regions of scar tissue within a patient's heart with autologous muscle cells or cells from a patient's... USRM Profile

Golden Star

Ticker	Date	Change	Price
CVBF	May 01	2.75%	$16.75
FTSL	May 01	0.282%	$46.03
EQC	Apr 30	0.694%	$18.72
HRB	Apr 30	0.635%	$47.23
BSCQ	Apr 30	0.576%	$19.09
BSJP	Apr 29	0.306%	$22.91
LYG	Apr 29	1.56%	$2.56
ORA	Apr 29	4.68%	$64.48
DHT	Apr 24	3.10%	$11.28
LPLA	Apr 19	3.12%	$262.59

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In

U.S. Stem Cell, Inc. Stock Predictions

USRM Predictions History

About U.S. Stem Cell, Inc.

Golden Star

Top Fintech Company